Neuberger Berman Group LLC - ALLOGENE THERAPEUTICS INC ownership

ALLOGENE THERAPEUTICS INC's ticker is ALLO and the CUSIP is 019770106. A total of 169 filers reported holding ALLOGENE THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 1.93 and the average weighting 0.2%.

Quarter-by-quarter ownership
Neuberger Berman Group LLC ownership history of ALLOGENE THERAPEUTICS INC
ValueSharesWeighting
Q3 2021$208,000
-1.4%
8,0850.0%0.00%
Q2 2021$211,000
-63.2%
8,085
-50.2%
0.00%
-100.0%
Q1 2021$574,000
+33.2%
16,246
-3.3%
0.00%
Q4 2020$431,000
-29.7%
16,801
+5.6%
0.00%
-100.0%
Q3 2020$613,000
+0.5%
15,910
+11.6%
0.00%0.0%
Q2 2020$610,000
+130.2%
14,260
+4.9%
0.00%
Q1 2020$265,00013,6000.00%
Other shareholders
ALLOGENE THERAPEUTICS INC shareholders Q3 2021
NameSharesValueWeighting ↓
VV Manager LLC 1,798,163$76,997,00067.53%
Wildcat Capital Management, LLC 1,515,524$64,895,00022.42%
TPG Group Holdings (SBS) Advisors, Inc. 19,716,306$844,252,00014.91%
REGENTS OF THE UNIVERSITY OF CALIFORNIA 1,279,281$54,779,0007.69%
Coastal Bridge Advisors, LLC 463,117$19,831,0006.33%
DSAM Partners (London) Ltd 235,098$10,067,0002.63%
Casdin Capital, LLC 625,000$26,763,0001.58%
Alpine Global Management, LLC 150,000$6,423,0001.13%
Perceptive Advisors 1,543,790$66,105,0001.07%
Avoro Capital Advisors LLC 1,128,594$48,326,0000.96%
View complete list of ALLOGENE THERAPEUTICS INC shareholders